Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats (2008)
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE, NEUTRÓFILOS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARSANTE, M. M. et al. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. British Journal of Pharmacology, v. 153, n. 5, p. 992-1002, 2008Tradução . . Disponível em: https://doi.org/10.1038/sj.bjp.0707462. Acesso em: 01 jun. 2024.APA
Barsante, M. M., Cunha, T. M., Allegretti, M., Cattani, F., Policani, F., Bizzarri, C., et al. (2008). Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. British Journal of Pharmacology, 153( 5), 992-1002. doi:10.1038/sj.bjp.0707462NLM
Barsante MM, Cunha TM, Allegretti M, Cattani F, Policani F, Bizzarri C, Tafuri WL, Poole S, Cunha F de Q, Bertini R, Teixeira MM. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats [Internet]. British Journal of Pharmacology. 2008 ; 153( 5): 992-1002.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/sj.bjp.0707462Vancouver
Barsante MM, Cunha TM, Allegretti M, Cattani F, Policani F, Bizzarri C, Tafuri WL, Poole S, Cunha F de Q, Bertini R, Teixeira MM. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats [Internet]. British Journal of Pharmacology. 2008 ; 153( 5): 992-1002.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/sj.bjp.0707462
